Neural Regeneration Research ›› 2026, Vol. 21 ›› Issue (10): 4729-4733.doi: 10.4103/NRR.NRR-D-25-01127

Previous Articles     Next Articles

Nuclear membrane disruption in neurodegenerative diseases: Emerging perspectives

Shuo Yuan1, 2, Nicholas Essepian1, Qingbo Wang1, 2, Lulu Jiang1, 2, *   

  1. 1Department of Neuroscience, University of Virginia School of Medicine, Charlottesville, VA, USA; 
    2Center for Brain Immunology and Glia (BIG), University of Virginia School of Medicine, Charlottesville, VA, USA
  • Online:2026-10-15 Published:2026-06-12
  • Contact: Lulu Jiang, MD, PhD, jiang.lulu@virginia.edu.
  • Supported by:
    This work was supported by NIH/NIA (R01AG091577), UVA Provost Award, UVA Health System, UVA Brain Institute Pitch and Catch Fund, Jim and Bruce Eck Fund, Strang Neuroscience Research Award (to LJ).

Abstract: The nucleus, as the largest organelle within the cell, serves as the central hub for storing, replicating, and transcribing genetic information, thereby orchestrating vital cellular processes. In eukaryotic cells, the nuclear membrane is composed of several structural components: the outer and inner nuclear membranes, the nuclear pore complexes, and the underlying nuclear lamina, which together preserve the stability of the intracellular environment. Neurodegenerative disorders, such as Alzheimer’s disease and related dementias, are characterized by the gradual degeneration and loss of neuronal structure and function in the central nervous system. Growing evidence suggests that alterations in nuclear envelope architecture are closely associated with the onset and progression of these diseases. This article summarizes the information, focusing on the regulators of the cell nuclear membrane, as well as its pathophysiological processes and regulatory mechanisms in neurodegenerative diseases. Moreover, this paper discusses related research advances that provide novel insights into a deeper understanding of the nuclear membrane in disease progression and its potential as a therapeutic target.

Key words: Alzheimer’s disease, neurodegenerative disease, nuclear invagination, nuclear lamina, nuclear membrane disruption, nuclear pore complex, nucleocytoplasmic transport, nucleoporin